Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains

Journal of Virological Methods
Yosuke YasuiTetsuo Nakayama

Abstract

Respiratory syncytial virus (RSV) consists of fusion (F), glyco (G), and small hydrophobic (SH) proteins as envelope proteins, and infects through cell fusion. F protein is expressed on the surface of infected cells, and induces cell fusion. In the present report, expression plasmids of the F, G and SH proteins were constructed and cell fusion activity was investigated under T7 RNA polymerase. F protein alone induced cell fusion at a lower concentration than previously reported, and co-expression of F and SH proteins induced cell fusion more efficiently than F protein alone. Palivizumab is the only prophylactic agent against RSV infection. Palivizumab-resistant strains having mutations of the F protein of K272E and S275F were reported. These mutations were introduced into an F-expression plasmid, and exhibited no inhibition of cell fusion with palivizumab. Among the RSV F protein mutants, N276S has been reported to have partial resistance against palivizumab, but the F expression plasmid with the N276S mutation showed a reduction in cell fusion in the presence of palivizumab, showing no resistance to palivizumab. The present expression system was useful for investigating the mechanisms of RSV cell fusion.

References

Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T R FuerstB Moss
Aug 1, 1997·The Journal of General Virology·M K Pastey, S K Samal
Aug 6, 2004·The Journal of Infectious Diseases·John P DeVincenzoFranco M Piazza
Mar 16, 2005·Journal of Virology·Xiaodong Zhao, Wayne M Sullender
Sep 29, 2006·Journal of Virology·Xiaodong ZhaoWayne M Sullender
May 12, 2007·Journal of Virology·Sandra FuentesBiao He
Dec 7, 2007·The European Respiratory Journal·D M Fleming, A J Elliot
Jan 3, 2008·The Pediatric Infectious Disease Journal·Kelly J Henrickson, Caroline Breese Hall
Jan 1, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Guy BoivinGaston De Serres
Jan 26, 2008·Animal Health Research Reviews·Laurel J Gershwin
Jun 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ortwin AdamsMarkus Vogel
Aug 16, 2011·Nature Medicine·Farnoosh TayyariRichard G Hegele
Jan 24, 2012·Emerging Infectious Diseases·Jesse PapenburgGuy Boivin
May 25, 2012·The Journal of Biological Chemistry·Siok-Wan GanJaume Torres
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Oct 5, 2013·The Journal of General Virology·Heather A LawlorRoderick S Tang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.